Clinical Trial Update: Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating intravitreal bevacizumab (Avastin) for diabetic retinopathy and retinal vein occlusion; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Diabetic Retinopathy
• Retinal Vein Occlusion

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetic Proliferative Retinopathy, Vascular Vein Oclussion | Phase 2, Phase 3 | Status: TERMINATED